X0202 SCHEDULE 13G/A 0001104659-26-061988 0001952142 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 06/30/2026 0001829802 Faeth Therapeutics, Inc. 81728A207 701 Tillery Street #12 #1010 Austin TX 78702 Rule 13d-1(b) StemPoint Capital LP DE 0.00 0.00 0.00 0.00 0.00 N 0.0 IA PN StemPoint Capital Management GP LLC DE 0.00 0.00 0.00 0.00 0.00 N 0.0 OO StemPoint Capital Management GP LLC is a limited liability company. Michelle Ross X1 0.00 0.00 0.00 0.00 0.00 N 0.0 HC IN Faeth Therapeutics, Inc. 701 Tillery Street #12 #1010, Austin, TX 78702 This filing is being jointly filed by StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross (collectively, the "Reporting Persons" and each a "Reporting Person"). The business addresses of each Reporting Person is: 520 Madison Avenue, 19th Floor New York, NY 10022 StemPoint Capital LP is a limited partnership organized under the laws of the State of Delaware. StemPoint Capital Management GP LLC is a limited liability company organized under the laws of the State of Delaware. Michelle Ross is a citizen of the United States of America. N IA HC Items 5-9 of each cover page are incorporated by reference. Each Reporting Person may be deemed to be the beneficial owner of 0 shares of Common Stock, $0.0001 par value per share (the "Common Stock"). Each Reporting Person may be deemed to beneficially own 0.0% shares of Common Stock, which is calculated based on 25,778,754 shares of Common Stock reported as issued and outstanding as of June 15, 2026, in Form 8-K filed with the Securities and Exchange Commission on June 18, 2026. -0- 0. -0- 0. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) StemPoint Capital LP /s/ Sean C. Tan 08/14/2026 StemPoint Capital Management GP LLC /s/ Sean C. Tan 08/14/2026 Michelle Ross /s/ Michelle Ross 08/14/2026